Clinical Trial Update: A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating stereotactic radiotherapy for oligoprogressive metastases in metastatic renal cell carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Metastatic Renal Cell Carcinoma, Radiotherapy | Phase 2 | Status: RECRUITING